High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Study Objectives
Long-term dopamine agonist (DA) use in restless legs syndrome (RLS) is associated with augmentation, a dose-related symptom worsening leading to further dose escalation to manage RLS. This study investigated rates and factors of high-dose DA prescribing in US RLS patients.
Methods
This retrospective analysis ex...
Alternative Titles
Full title
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8842153
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8842153
Other Identifiers
ISSN
0161-8105
E-ISSN
1550-9109
DOI
10.1093/sleep/zsab212
